Client News

TAI'AN CITY, Shandong, China, May 18 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ('CBP,' or the 'Company'), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ('PRC'), today announced that it will host a conference call at 8:00 a.m. EDT on Tuesday, May 19, 2009, to discuss the 2009 first quarter financial results.

Hosting the call will be Mr. Colin Zhao, Chief Executive Officer, and Mr. Tristan Kuo, Chief Financial Officer.

TAIAN CITY, Shandong, China, May 15 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) (''China Biologic'' or the ''Company''), one of the leading plasma-based pharmaceutical companies in the People's Republic of China (''PRC''), today announced that the Company's management will present at the upcoming China Rising Conference hosted by CCG Investor Relations in New York, NY on May 18, 2009 and the 3rd Annual China Dragon Call Conference hosted by Oppenheimer & Co. Inc. on May 19 to 21, 2009.

TAIAN CITY, China, April 27 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ('China Biologic' or the 'Company'), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ('PRC'), today announced that the Company received an order from one of the largest authorized biopharmaceutical distributors in India, to ship Company products valued at $5.3 million to be sold under the Company's own brand.

JUNAN COUNTY, China, May 15 /PRNewswire-Asia-FirstCall/ -- American Lorain Corporation (OTC Bulletin Board: ALRC) ('American Lorain' or the 'Company'), an international processed foods company based in Shandong Province, People's Republic of China ('PRC'), announced its financial results for the first quarter of fiscal year 2009 ended March 31, 2009.

First Quarter 2009 Highlights

-- Revenue increased 21.6% year-over-year to $21.2 million
-- Gross profit increased 30.8% year-over-year to $5.2 million

JUNAN COUNTY, China, May 13 /PRNewswire-Asia-FirstCall/ -- American Lorain Corporation (OTC Bulletin Board: ALRC)('American Lorain' or the 'Company'), an international processed foods company based in Shandong Province, People's Republic of China ('PRC'), today announced that it will host a conference call at 9:00 a.m. EDT on Friday, May 15, 2009, to discuss the Company's financial results for the first quarter 2009.

JUNAN COUNTY, Shandong, China, May 8 /PRNewswire-Asia-FirstCall/ -- American Lorain Corporation (OTC Bulletin Board: ALRC) ('American Lorain' or the 'Company'), an international processed foods company based in Shandong Province, People's Republic of China ('PRC'), announced today that the Company's management will present at the upcoming China Rising Conference hosted by CCG Investor Relations in New York, NY on May 18, 2009.

The date, time and location of American Lorain's presentation at the China Rising Conference are as follows:

Date: Monday, May 18, 2009

Beijing, January 02, 2009 - China TransInfo Technology Corp., (Nasdaq Capital Market: CTFO), ("China TransInfo" or "the Company"), a leading provider of public transportation information systems technology and comprehensive solutions in the People’s Republic of China (“PRC”), today announced that, through its majority owned subsidiary Dalian Dajian Zhitong Information Service Co., Ltd (Dajian Zhitong), it has entered into a 5-year taxi advertisement placement agreement with Dalian Liyang Media Limited (“Dalian Liyang”).

Laiyang, China, April 23, 2009 – Genesis Pharmaceuticals Enterprises, Inc. (OTC Bulletin Board: GNPH) (the “Company”), a U.S. pharmaceutical company with its principal operations in the People's Republic of China, today announced that it has changed its name to “Jiangbo Pharmaceuticals, Inc.” (“Jiangbo”).

Harbin, China, April 23, 2009 -- China Sky One Medical, Inc. (“China Sky One Medical” or “the Company”) (NASDAQ: CSKI), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People’s Republic of China (“PRC”), today announced that it obtained approvals from the State Food and Drug Administration (SFDA) in China for the production of Geranium ointment and Musk liniment for pain relief.

Laiyang, China, April 22, 2009 – Genesis Pharmaceuticals Enterprises, Inc. (OTC Bulletin Board: GNPH) (“Genesis” or the “Company”), a U.S. pharmaceutical company with its principal operations in the People's Republic of China, today announced that it began marketing and selling three Traditional Chinese Medicines (“TCMs”). These TCMs are Yi Mu Cao Gao (a motherwort herb electuary sticky syrup), Gan Mao Zhi Ke Ke Li (an antipyretic and antitussive granule), and Kang Gu Sui Yan Pian (an osteomyelitis treatment tablet).